Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03492489	Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma	no longer available	—	—	Regeneron PharmaceuticalsINDUSTRY	0	Aug 1, 2019	clinicaltrials
NCT01728051	Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver	no longer available	—	—	Delcath Systems Inc.INDUSTRY	1	Oct 23, 2013